Search Results
Mar 03, 2026, 17:31 ET Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Eli Lilly and Company, Shandong Suncadia Medicine, Boehringer Ingelheim, AdAlta, Alebund Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, Roche, MC2 Therapeutics, Allena Pharmaceuticals, Regulus Therapeutics, UnicoCell Biomed, Regeneron Pharmaceuticals, and others.
More news about: DelveInsight Business Research, LLP
Mar 03, 2026, 09:00 ET Tarps Plus Highlights the Essential Role of Tarps in Spring Construction and Agricultural Operations
residential, commercial, and government customers nationwide, offering poly, vinyl, canvas, and mesh solutions engineered for real-world performance.MC: Media Contact:Michael SteinFounder, Tarps PlusEmail: [email protected]:
More news about: Tarps Plus
Mar 03, 2026, 08:01 ET TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients
financing and licensing agreements can be found in TransCode's Form 8-K filed with the U.S Securities and Exchange Commission.About TTX-MC138TTX-MC138 is a first-in-class therapeutic candidate designed to inhibit microRNA-10b, or miR-10b, a microRNA widely believed to be critical to the
More news about: TransCode Therapeutics, Inc.
Mar 02, 2026, 17:00 ET Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs
different functional states to enable a highly differentiated approach to small-molecule discovery.Congruence's wholly owned program directed to MC4R-deficient genetic obesity is entering a Phase 1/1b clinical study this month. In the next few weeks, Congruence will also nominate development candidates
More news about: Congruence Therapeutics
Feb 28, 2026, 09:45 ET Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
neurocognitive) and most severe symptom per the ISM Symptom Assessment Form (ISM-SAF), and quality of life per the Mastocytosis Quality of Life Questionnaire (MC-QoL).In patients with frequent episodes of diarrhea at baseline and at least four years of AYVAKIT (n=44), the median reduction in diarrhea frequency
More news about: Blueprint Medicines, a Sanofi company
Feb 27, 2026, 08:39 ET Montgomery College's Bridget Lowrie Selected for 2026 Smithsonian Faculty Fellowship
Bridget Lowrie has been selected for the 2026 MC-Smithsonian Faculty Fellowship cohort, a yearlong academic partnership that connects college classrooms with Smithsonian collections, scholars, and digital
More news about: Bridget Lowrie
Feb 26, 2026, 08:00 ET SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
([email protected])Moonchel Kim ([email protected])
More news about: SK bioscience
Feb 24, 2026, 10:25 ET Facilitron Acquires MC², Strengthening Infrastructure Leadership in Strategic Facilities Management
acquisition, Facilitron will transition MC²'s customer base onto Works, modernizing those relationships within a scalable infrastructure designed to support real-time operational visibility and long-term capital stewardship.Founded more than four decades ago, MC² built enduring relationships
More news about: Facilitron
Feb 24, 2026, 07:00 ET Housecall Pro unveils most-requested platform upgrades, turning feedback into action
https://housecallpro.registration.goldcast.io/webinar/246a8041-f402-42a4-a364-815dc4775eeb?utm_source=press-release&utm_medium=external-page&utm_campaign=en_ga_Feb26_Release_Moment&mc=Release+Moment&msc=en_ga_Feb26_Release_Moment.For more information
More news about: Housecall Pro
Feb 23, 2026, 08:01 ET TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
stage company pioneering immuno-oncology and RNA therapeutic treatments for high risk and advanced cancers. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors that overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode's
More news about: TransCode Therapeutics, Inc.
Feb 22, 2026, 04:51 ET Lenire muestra resultados positivos consistentes para pacientes con tinnitus en Estados Unidos
menos de forma moderada por su tinnitus tienen una puntuación THI de 38 o más y entran en las categorías de moderado, grave y catastrófico.3. Mc Mahan, E. y Lim, H. Revisión retrospectiva de historias clínicas que demuestra la eficacia de la neuromodulación bimodal para el tratamiento del tinnitus
More news about: Neuromod Devices
Feb 18, 2026, 07:30 ET First Patients Dosed in Alphyn Biologics' Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum
treatment for MC that is safe, pain-free, gentle and effective. Current office surgical procedures such as curettage, cautery and cryotherapy can be painful and difficult for children to tolerate. While there are two new FDA approved treatments for MC, new safe, effective and pain-free options for MC treatment
More news about: Alphyn Biologics, Inc.
Feb 17, 2026, 12:54 ET Lenire zeigt durchgängig positive Ergebnisse für Tinnitus-Patienten in den USA in der zweiten Peer-Review-Real-World-Studie
mäßig von ihrem Tinnitus betroffen sind, haben einen THI-Wert von 38 und mehr und fallen in die Kategorien mittelschwer, schwer und katastrophal.Mc Mahan, E., und Lim, H. Retrospektive Übersichtsarbeit zum Nachweis der Wirksamkeit der bimodalen Neuromodulation bei der Tinnitus-Behandlung in einem
More news about: Neuromod Devices
Feb 17, 2026, 07:30 ET Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
differentiated MC4R-based obesity programs into clinical developmentMelanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary focus on hypothalamic obesity and Prader-Willi syndromeOral small-molecule MC4R agonist PL7737
More news about: Palatin Technologies, Inc.
Feb 17, 2026, 05:30 ET Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
least moderately affected by their tinnitus have a THI score of 38 and above and fall into the moderate, severe and catastrophic categories.Mc Mahan, E., and Lim, H. Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
least moderately affected by their tinnitus have a THI score of 38 and above and fall into the moderate, severe and catastrophic categories.Mc Mahan, E., and Lim, H. Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire montre des résultats positifs constants pour les patients américains souffrant d'acouphènes dans une deuxième étude en situation réelle évaluée par des pairs.
moins modérément affectés par leurs acouphènes ont un score THI de 38 et plus et entrent dans les catégories Modéré, Sévère et Catastrophique.Mc Mahan, E., et Lim, H. Examen rétrospectif des dossiers démontrant l'efficacité de la neuromodulation bimodale pour le traitement des acouphènes dans
More news about: Neuromod Devices
Feb 16, 2026, 07:00 ET Central Holidays Debuts Inspiring New Line of Travel Programs to Morocco - Immersive Cultural Journeys, Custom Experiences, and Advisor-First Support Take Center Stage
BookingsValid for Morocco bookings requested and deposited after February 1, 2026Travel must depart by December 31, 2026Promo Code: WENR100MC must be mentioned at the time of bookingThis special cannot be combined with other offers.Central Holidays is Built for Advisors
More news about: Central Holidays
Feb 13, 2026, 08:00 ET Qubs Showcases Range of Tech-Powered, Screen-Free Toys at its New York Toy Fair® Debut
create your own calm. Add the Forest Dreams & Firelight expansion set to create your own cocoon of calm. Available April 2026.MC Mutts (4+): Meet the MC Mutts, four dogs with serious groove. Mix rap, beats and rhymes to create your own tracks. Available June 2026.Jurassic Sounds
More news about: QUBS
Feb 12, 2026, 20:08 ET 工場直接取引でホーム&ライフスタイル製品を調達：中国日用百貨商品交易会、今年7月に開幕
https://reed.infosalons.com.cn/reg/RXWeb/cda26/#/en/login?track=E365MC詳細はこちら（日本語）： https://www.cdatf.com/ja.htmlRX
More news about: RX Huabai
Feb 12, 2026, 09:00 ET Sourcing with Direct Factories at One-stop Consumer Goods Sourcing Platform: China Daily-use Articles Trade Fair to Kick Off This July
badge:https://reed.infosalons.com.cn/reg/RXWeb/cda26/#/en/login?track=E365MCFor more information:https://www.cdatf.com/en-gb/about.htmlCDATF
More news about: RX Huabai
Feb 12, 2026, 01:23 ET 아시아 원스톱 홈 & 라이프스타일 소싱 플랫폼 중국 일용품 무역 박람회 7월 개최
등록:https://reed.infosalons.com.cn/reg/RXWeb/cda26/#/en/login?track=E365MC자세한 정보:https://www.cdatf.com/ko.htmlRX
More news about: RX Huabai
Feb 11, 2026, 06:55 ET Jimmie Johnson Unveils "Helmet of Heroes" Tribute at DAYTONA 500 Honoring Fallen Firefighters in Partnership with Pye-Barker Fire & Safety, Driving Carvana No. 84
legend and Hall of Famer Richard Petty, "The King", serving as CLUB Ambassador, LEGACY MC blends timeless racing traditions with a new forward-thinking vision. As an inclusive community for motorsport enthusiasts, LEGACY MC honors both its storied past and the promising future of its members, always striving
More news about: Pye-Barker Fire & Safety
Feb 11, 2026, 04:55 ET NetEase Cloud Music Inc. Reports Fiscal Year 2025 Financial Results
as hip-hop, Japanese ACG and Western music. This included the latest releases from popular rappers and rock bands such as KeyNG (楊和蘇), MaSiWei (馬思唯), MC HotDog (熱狗), New Pants (新褲子) and Reflector (反光鏡). We also partnered with Kadokawa and U/M/A/A, and collaborated closely with Deco*27 to bring more high-quality J-Pop
More news about: NetEase Cloud Music
Feb 09, 2026, 01:50 ET Skanska rebuilds middle school in Tampa, Florida, USA, for USD 77M, about SEK 720M
https://news.cision.com/skanska/r/skanska-rebuilds-middle-school-in-tampa--florida--usa--for-usd-77m--about-sek-720m,c4304430The following files are available for download:
More news about: Skanska